News & Updates

Several medications such as orodispersible budesonide (ODB), oral viscous budesonide (OVB), and fluticasone, among others, demonstrate efficacy in the treatment of eosinophilic esophagitis (EoE) in adults and children, according to the results of a network meta-analysis.

Biweekly single-dose actinomycin-D (Act-D) is superior to 8-day methotrexate (MTX) regimen as first-line single-agent chemotherapy in patients with low-risk gestational trophoblastic neoplasia (GTN), as shown by a study presented at SGO 2025.

Digital interventions such as mobile apps, reminder systems, and wearable devices, among others, may be a useful tool in ensuring patients adhere to their oral systemic anticancer therapy, according to a systematic review and meta-analysis.

New drug applications approved by US FDA as of 1-15 April 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

In the management of diabetes, users of glucagon-like peptide-1 receptor agonists (GLP-1RAs) appear to have a lower risk of all-cause dementia compared with users of other glucose-lowering medications, according to a systematic review and meta-analysis.

A recent study found that self-perceived stress may increase the risk of early-onset cryptogenic ischaemic stroke (CIS) in young adults, particularly women.